Switch from tablet levothyroxine to oral solution resolved reduced absorption by intestinal parasitosis

Reduced intestinal absorption of levothyroxine (LT4) is the most common cause of failure to achieve an adequate therapeutic target in hypothyroid patients under replacement therapy. We present the case of a 63-year-old woman with autoimmune hypothyroidism previously well-replaced with tablet LT4 who...

Descripción completa

Detalles Bibliográficos
Autores principales: Tortora, Anna, La Sala, Domenico, Vitale, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2019
Materias:
Novel Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432983/
https://www.ncbi.nlm.nih.gov/pubmed/30897550
http://dx.doi.org/10.1530/EDM-19-0026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432983/
https://www.ncbi.nlm.nih.gov/pubmed/30897550
http://dx.doi.org/10.1530/EDM-19-0026

Ejemplares similares